Manchester Capital Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-64
| Closed | -$4.84K | – | 1334 |
|
|
2026
Q1 | $4.84K | Hold |
64
| – | – | ﹤0.01% | 896 |
|
|
2025
Q4 | $4.77K | Sell |
64
-35
| -35% | -$2.56K | ﹤0.01% | 893 |
|
|
2025
Q3 | $6.68K | Sell |
99
-24
| -20% | -$1.59K | ﹤0.01% | 917 |
|
|
2025
Q2 | $8.02K | Buy |
123
+23
| +23% | +$1.38K | ﹤0.01% | 850 |
|
|
2025
Q1 | $6.18K | Buy |
100
+28
| +39% | +$1.85K | ﹤0.01% | 875 |
|
|
2024
Q4 | $5.19K | Sell |
72
-3
| -4% | -$234 | ﹤0.01% | 887 |
|
|
2024
Q3 | $6.11K | Buy |
75
+32
| +74% | +$2.56K | ﹤0.01% | 863 |
|
|
2024
Q2 | $3.19K | Buy |
43
+3
| +8% | +$225 | ﹤0.01% | 905 |
|
|
2024
Q1 | $3.12K | Sell |
40
-319
| -89% | -$23.7K | ﹤0.01% | 794 |
|
|
2023
Q4 | $25.7K | Buy |
359
+32
| +10% | +$2.23K | ﹤0.01% | 505 |
|
|
2023
Q3 | $22.7K | Buy |
+327
| New | +$24.7K | ﹤0.01% | 513 |
|
|
2023
Q2 | – | Sell |
-27
| Closed | -$2.18K | – | 1041 |
|
|
2023
Q1 | $2.18K | Hold |
27
| – | – | ﹤0.01% | 774 |
|
|
2022
Q4 | $2.02K | Buy |
+27
| New | +$1.92K | ﹤0.01% | 695 |
|
|
2022
Q1 | – | Sell |
-150
| Closed | -$11K | – | 1071 |
|
|
2021
Q4 | $11K | Buy |
+150
| New | +$11K | ﹤0.01% | 554 |
|
|
2021
Q1 | – | Sell |
-11
| Closed | -$1K | – | 704 |
|
|
2020
Q4 | $1K | Buy |
11
+7
| +175% | +$494 | ﹤0.01% | 655 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | +$253 | ﹤0.01% | 615 |
|
|
2019
Q2 | – | Sell |
-120
| Closed | -$6K | – | 596 |
|
|
2019
Q1 | $6K | Buy |
+120
| New | +$5.41K | ﹤0.01% | 596 |
|
Other funds holding HOLX
Manchester Capital Management's HOLX Position: Q2 2026 in Review
Manchester Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 64 shares — an estimated $4.84K sold.
Manchester Capital Management first reported a position in HOLX in Q1 2019 and held it in 17 quarters. The position peaked at $25.7K in Q4 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Manchester Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Manchester Capital Management sold 64 Hologic shares in Q2 2026, an estimated $4.84K.
- Manchester Capital Management first reported a position in Hologic in Q1 2019 and held it in 17 quarters.
- Manchester Capital Management's Hologic position peaked at $25.7K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.